This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.
The Office of Drug Control (ODC) issues several license types, including: Cultivation growing cannabis for medicinal or research purposes. Research studying cannabis for medicinal development. Businesses should also investigate potential research and development (R&D) incentives if applicable.
Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? HI resident? KY resident?
Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. 1 So can cannabis cure cancer? The answer: Maybe!
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.
The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. What does federally funded cannabis research mean for medical marijuana development?
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.
The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.
(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). About Field Trip Health Ltd. KCSA Strategic Communications.
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” Although it is true that psychedelic consumers do report many psychosis-like symptoms, this can be attributed to the use of other psychoactive drugs and pre-existing or underlying mental health conditions. .
Ohio State Legal Studies Research Paper No. According to its sponsors and supporters, the Safe and Fair Enforcement (‘SAFE’) Banking Act would help address the challenges faced by small cannabis businesses that cannot currently access banking services or loans. Ohio State Legal Studies Research Paper No. Cat Packer.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. The market for medical cannabis in Germany. About Curaleaf International. About Zambon Spa.
million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.
Not only in the acceptance of the plant as a medicine, but the number of people who have access to this alternative and our understanding of how it works with our bodies. As research has developed, the list of qualifying conditions for getting a medical marijuana card has expanded within medical programs because.
Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.
She also signed bills to allow medical cannabis to be administered to patients while at school, and a broader medical expansion bill that adds several new qualifying conditions and patient protections. Governor Jared Polis (D) of Colorado signed legislation into law to add autism as a medical cannabis qualifying condition. CA resident?
As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. According to Eric Brown , lead researcher in the study at McMaster University: These findings suggest real therapeutic potential for cannabinoids as antibiotics. Medical Marijuana & MRSA.
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.
Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .
The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).
On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. But what truly matters is how these improvements translate into real life.
While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. It’s heartening to see the release of more and more evidence-based global research surrounding Medical Cannabis-based treatment.
At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.
West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditionsaccess to medical cannabis as an alternative treatment option. In this guide, we’ll break down everything you need to know to start accessing medical marijuana in West Virginia.
At the heart of it, it becomes about patients who have one (or many) of the qualifying conditions. Qualifying Conditions for Medical Marijuana in Pennsylvania Pennsylvania’s Medical Marijuana Program provides legal access to medical cannabis for patients diagnosed with a range of qualifying conditions.
Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.
Researchers wanted to evaluate the potential association between cannabis use and respiratory-related emergency room visits and hospitalizations. This study was observational in the sense that the researchers did not directly interact with participants and merely conducted reviews of health records and surveys. Focused on the Negative.
Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.
Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.
Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction. We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally.
Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.
The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.
A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.
The developmental condition can be difficult to manage in severe cases, putting the individual and their family members under a great deal of stress. A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D. The researchers were able to alleviate the symptoms of autism in animal models using THC-rich cannabis oil.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content